MIRUM PHARMA INC FDA Approval NDA 214662

NDA 214662

MIRUM PHARMA INC

FDA Drug Application

Application #214662

Documents

Label2021-09-29
Letter2021-09-30

Application Sponsors

NDA 214662MIRUM PHARMA INC

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL9.5MG0LIVMARLIMARALIXIBAT CHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2021-09-29PRIORITY

Submissions Property Types

ORIG1Null7

CDER Filings

MIRUM PHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214662
            [companyName] => MIRUM PHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LIVMARLI","activeIngredients":"MARALIXIBAT CHLORIDE","strength":"9.5MG","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"09\/29\/2021","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/214662s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"09\/29\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity","reviewPriority":"PRIORITY; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/214662s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/214662Orig1s000ltr.pdf\"}]","notes":">"}]
            [supplements] => 
            [actionDate] => 2021-09-29
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.